Price Indexes for Drugs (original) (raw)

This paper explores the complexities of constructing price indexes for drugs, emphasizing their significance in understanding health care spending and productivity. It discusses various measurement challenges, including quality adjustments and the disconnect between price changes and patient welfare. The organization of the paper includes a focus on definitional issues, aggregation methods, and a review of quality change, aimed at improving price index construction methodologies in the medical care sector.